Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study
Clinical trial NCT03723512 · COMPLETED
Trial details
- NCT number
- NCT03723512
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2021-02-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.